Vascular News 42 – May 2009

291

Highlights: -NICE UK concludes that EVAR is cost-effective -Endovascular aortic questions to be settled by individual patient data meta-analysis -Kabnick: Limitations of the RECOVERY trial -Pedrini: TASC II guidelines are little help -Profile: John Mannick

(Visited 13 times, 1 visits today)